ASH Clinical News December 2016 | Page 9

VOLUME 02 | NUMBER 12 | DECEMBER 2016 Around the Network AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: [phone] IN THIS ISSUE drawing first blood To Test or Not to Test? EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS Larisa H. Cavallari, PharmD, and Bruce Furie, MD, to debate the question: “Is there a role for pharmacogenomic testing in guiding initial warfarin dosing?” Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH 98 clinical news ASSOCIATE EDITORS 43 H  IT or Miss? Comparing Cost-Effectiveness Beth Faiman, CNP, PhD of Heparin-Induced Thrombocytopenia Treatment Cleveland Clinic Cleveland, OH Alice Ma, MD University of North Carolina School of Medicine Chapel Hill, NC David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ PUBLISHER Who’s In and Who’s Out? 55 Introducing “Blood Advances in a Different Vein” To make sure clinical trials provide reproducible, valuable results, investigators design the protocols with strict inclusion and exclusion criteria. Many have called into question whether those criteria are too strict, and if the populations enrolled in randomized clinical trials accurately reflect their real-world counterparts. 71 Nearly One in Six Patients Hospitalized for First-Time Syncope Have Pulmonary Embolism 90 American Medical Communications (AMC) EDITORIAL MANAGING EDITORS Ariel Jones-DeMaio, AMC Karen Learner, ASH ASSOCIATE MANAGING EDITOR Kerri Fitzgerald, AMC ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ADVERTISING ACCOUNT MANAGER Nick Luciano [email protected] Gene Conselyea [email protected] Recruitment advertising orders can be sent to: DIRECTOR, RECRUITMENT CLASSIFIEDS Lauren Morgan [email protected] ASHCLINICALNEWS.ORG With more than 4,800 abstracts and over 150 sessions, the 58th ASH Annual Meeting & Exposition is jam-packed with practice-changing science, educational activities, and networking opportunities. Looking for some guidance on what to add to your schedule? Check out our Annual Meeting Preview on page 74 for an insider’s perspective on this year’s program, and take a look at some of the behind-thescenes work on this year’s meeting in the special ASH Annual Meeting Edition of Data Stream on page 38. We will also be on site to update our readers on the latest news from @ASHCLINICALNEWS the meeting. Not attending the annual meeting? ASH Clinical News will be your eyes and ears! Check our “On Location” section for daily updates from the meeting: ashclinicalnews.org/ on-location Watch our exclusive interviews with presenters and experts in our “Multimedia” section: ashclinicalnews.org/ multimedia/exclusive-videos Check us out on Twitter for on-site updates from the annual meeting: @ASHClinicalNews Follow the conversation by searching #ASH16 You can also sign up to receive our e-newsletters to have the latest annual meeting news delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up CORRECTION: In our November issue, on page 16, we published the incorrect photo for Angelo Cardoso, MD, PhD. We apologize for the error. Angelo Cardoso, MD, PhD Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews ©2016 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or otherwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. ASHClinicalNews.org Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is assumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published once per month by American Medical Communications, 630 Madison Avenue, 2nd Floor,